Skip to main content
Premium Trial:

Request an Annual Quote

NuGEN Technologies

NuGEN Technologies this week launched Ovation RNA Amplification System Version 2, a modular amplification system for RNA from any source that enables analysis on the Affymetrix GeneChip without a need for globin reduction.
The new Ovation system replaces Ovation RNA Biotin Amplification and Labeling System when used in conjunction with the company’s FL-Ovation cDNA Biotin Module V2, NuGEN said.
NuGEN also launched its Ovation WB Reagent that it claims enables gene expression analysis of as little as 20 nanograms of whole blood RNA on GeneChip arrays without the need for Globin reduction.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.